Olaratumab Intravenous and Pioglitazone and Metformin Extended-Release Tablets
Determining the interaction of Olaratumab Intravenous and Pioglitazone and Metformin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: olaratumab
Brand name: Lartruvo
Synonyms: Olaratumab
Generic Name: metformin / pioglitazone
Brand name: Actoplus Met, Actoplus Met XR
Synonyms: Metformin and pioglitazone, Pioglitazone and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Olaratumab Intravenous-Pioglitazone and Metformin Tablets
- Olaratumab Intravenous-Pioglitazone Hydrochloride
- Olaratumab Intravenous-Pioglitazone Tablets
- Olaratumab Intravenous-Piperacillin
- Olaratumab Intravenous-Piperacillin and tazobactam
- Olaratumab Intravenous-Piperacillin and tazobactam Intravenous
- Pioglitazone and Metformin Extended-Release Tablets-Oleptro
- Pioglitazone and Metformin Extended-Release Tablets-Oleptro Oral
- Pioglitazone and Metformin Extended-Release Tablets-Olmesartan
- Pioglitazone and Metformin Extended-Release Tablets-Olmesartan and Hydrochlorothiazide
- Pioglitazone and Metformin Extended-Release Tablets-Olmesartan Medoxomil
- Pioglitazone and Metformin Extended-Release Tablets-Olmesartan Medoxomil and Hydrochlorothiazide